Association between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection

Open Forum Infectious Diseases

Volumn 2, Issue 3, 2015, Pages

  Dantes, Raymund ^a   Mu, Yi ^a   Hicks, Lauri A ^a   Cohen, Jessica ^a,b   Bamberg, Wendy ^c   Beldavs, Zintars G ^d   Dumyati, Ghinwa ^e   Farley, Monica M ^f,g   Holzbauer, Stacy ^h   Meek, James ⁱ   Phipps, Erin ^j   Wilson, Lucy ^k,l   Winston, Lisa G ^m,n   McDonald, L Clifford ^a   Lessa, Fernanda C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^c Colorado Department of Public Health and Environment ^*  (United States)

^d OREGON HEALTH AUTHORITY   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f EMORY UNIVERSITY   (United States)

^g ATLANTA VA MEDICAL CENTER   (United States)

^h MINNESOTA DEPARTMENT OF HEALTH   (United States)

ⁱ Connecticut Emerging Infections Program ^*  (United States)

^j UNIVERSITY OF NEW MEXICO   (United States)

^k California Emerging Infections Prog   (United States)

^l JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ SAN FRANCISCO GENERAL HOSPITAL   (United States)

more..

Author keywords

antibacterial agents; Clostridium difficile; epidemiology; outpatients; public health surveillance

Indexed keywords

EID: 85013851685     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/OFID/OFV113     Document Type: Article

References (39)

1. Lucado J, Gould C, Elixhauser A. Clostridium Difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD, 2011.
2. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. 2013; Available at: http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed 12 December 2014.
3. Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk–four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1201–5.
4. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile–Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:340–3.
5. Kutty PK, Woods CW, Sena AC, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010; 16:197–204.
6. Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis 1998; 26:141–5.
7. Lessa FC. Community-associated Clostridium difficile infection: how real is it? Anaerobe 2013; 24:121–3.
8. Dumyati G, Stevens V, Hannett GE, et al. Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerg Infect Dis 2012; 18:392–400.
9. Deshpande A, Pasupuleti V, Thota P, et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 2013; 68:1951–61.
10. Hicks LA, Taylor TH Jr, Hunkler RJ. U.S. outpatient antibiotic prescribing, 2010. N Engl J Med 2013; 368:1461–2.
11. Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. J Antimicrob Chemother 2014; 69:234–40.
12. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013; 173:1359–67.
13. Lessa FC, Mu Y, Winston LG, et al. Determinants of Clostridium difficile infection incidence across diverse United States geographic locations. Open Forum Infect Dis 2014; 1:ofu048.
14. Cohen J, Limbago B, Dumyati G, et al. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States. J Clin Microbiol 2014; 52:632–4.
15. National Center for Health Statistics. Vintage 2011 Bridged-race postcensal population estimates for July 1, 2010 - July 1, 2011, by year, county, single-year of age (0 to 85+ years), bridged-race, Hispanic origin, and sex. Available at: http://www.cdc.gov/nchs/nvss/bridged_race.htm. Accessed 23 August 2013.
16. Ranji SR, Steinman MA, Shojania KG, Gonzales R. Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis. Medical Care 2008; 46:847–62.
17. Gill JM, Fleischut P, Haas S, et al. Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study. Fam Med 2006; 38:349–54.
18. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009; 302:758–66.
19. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2014; 3:CD000245.
20. Little P, Stuart B, Moore M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013; 13:123–9.
21. Barnett ML, Linder JA. Antibiotic prescribing to adults with sore throat in the United States, 1997–2010. JAMA Intern Med 2014; 174:138–40.
22. Wessels MR. Clinical practice. Streptococcal pharyngitis. N Engl J Med 2011; 364:648–55.
23. Barnett ML, Linder JA. Antibiotic prescribing for adults with acute bronchitis in the United States, 1996–2010. JAMA 2014; 311:2020–2.
24. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005; CD003539.
25. Gonzales R, Corbett KK, Wong S, et al. “Get smart Colorado”: impact of a mass media campaign to improve community antibiotic use. Medical Care 2008; 46:597–605.
26. Centers for Disease Control and Prevention. Get Smart: Know When Antibiotics Work. Available at: http://www.cdc.gov/getsmart/. Accessed 22 October 2013.
27. Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis 2007; 44:769–74.
28. Vernacchio L, Vezina RM, Mitchell AA. Management of acute otitis media by primary care physicians: trends since the release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians clinical practice guideline. Pediatrics 2007; 120:281–7.
29. Linder JA, Schnipper JL, Tsurikova R, et al. Self-reported familiarity with acute respiratory infection guidelines and antibiotic prescribing in primary care. Int J Qual Health Care 2010; 22:469–75.
30. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc 2007; 138:739–45, 47–60.
31. Rethman MP, Watters W III, Abt E, et al. The American Academy of Orthopaedic Surgeons and the American Dental Association clinical practice guideline on the prevention of orthopaedic implant infection in patients undergoing dental procedures. J Bone Joint Surg Am 2013; 95:745–7.
32. Kallen AJ, Thompson A, Ristaino P, et al. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol 2009; 30:264–72.
33. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41:1254–60.
34. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442–9.
35. Wilcox MH, Shetty N, Fawley WN, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 2012; 55:1056–63.
36. Limbago BM, Long CM, Thompson AD, et al. Clostridium difficile strains from community-associated infections. J Clin Microbiol 2009; 47:3004–7.
37. Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010; 50:194–201.
38. Ma J, Stafford RS. Quality of US outpatient care: temporal changes and racial/ethnic disparities. Arch Intern Med 2005; 165:1354–61.
39. Vanderweil SG, Tsai CL, Pelletier AJ, et al. Inappropriate use of antibiotics for acute asthma in United States emergency departments. Acad Emerg Med 2008; 15:736–43.